The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix

被引:31
作者
Chang, JL
Tsao, YP
Liu, DW
Han, CP
Lee, WH
Chen, SL [1 ]
机构
[1] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan
[2] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan
[3] TriServ Gen Hosp, Dept Pathol, Taipei, Taiwan
[4] 803 Army Gen Hosp, Dept Obstet & Gynecol, Taichung, Taiwan
关键词
growth factor receptor; cervical carcinoma; immunohistochemistry;
D O I
10.1006/gyno.1998.5301
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim. The type I family of growth factor receptors includes ErbB1, ErbB2, ErbB3, and ErbB4 which are frequently overexpressed in various human cancer cells, In this study, we systematically investigated the frequency and distribution of these four receptors in relation to neoplastic changes and tumor behaviors in the uterine cervix, Materials, A total 84 of cases including 12 cases of normal cervical tissues, 6 cases of low grade squamous intraepithelial lesion, 10 cases of high grade squamous intraepithelial lesion, and 56 cases of squamous cells carcinoma were examined. Results. Our results show significant difference with increasing grades of dysplasia in terms of these four receptor expressions, No association was found between these four receptors acid cell keratinization/differentiation of squamous cell carcinoma of the cervix. Of the four receptors studied, only the expression of erbB2/neu gene was significantly associated with lymph nodal metastasis. Moreover, we find that the coexpression of ErbB1 and ErbB4 was significant in cervical carcinoma. Conclusions. The coexpression of ErbB1 and ErbB4 in cervical carcinoma suggests that they may be involved in receptor heterodimerization leading to the activation of signaling pathway in the cervical carcinoma. (C) 1999 Academic Press.
引用
收藏
页码:62 / 71
页数:10
相关论文
共 23 条
  • [1] BERCHUCK A, 1990, OBSTET GYNECOL, V76, P381
  • [2] IN HIV-INFECTED INDIVIDUALS WHO DESIRE COMBINATION ANTIVIRAL THERAPY, ZIDOVUDINE PLUS ZALCITABINE IS PREFERRED TO ZIDOVUDINE PLUS DIDANOSINE
    CARR, A
    COOPER, DA
    [J]. REVIEWS IN MEDICAL VIROLOGY, 1994, 4 (01) : 5 - 8
  • [3] Cohen BM, 1996, J BIOL CHEM, V271, P4813
  • [4] SIGNALING BY RECEPTOR TYROSINE KINASES
    FANTL, WJ
    JOHNSON, DE
    WILLIAMS, LT
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 : 453 - 481
  • [5] PROGNOSTIC FACTORS IN UTERINE CERVICAL-CARCINOMA - A CLINICOPATHOLOGICAL ANALYSIS
    HALE, RJ
    WILCOX, FL
    BUCKLEY, CH
    TINDALL, VR
    RYDER, WDJ
    LOGUE, JP
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1991, 1 (01) : 19 - 23
  • [6] PROGNOSTIC VALUE OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN CERVICAL-CARCINOMA
    HALE, RJ
    BUCKLEY, CH
    GULLICK, WJ
    FOX, H
    WILLIAMS, J
    WILCOX, FL
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (02) : 149 - 153
  • [7] PROGNOSTIC VALUE OF C-ERBB-2 EXPRESSION IN UTERINE CERVICAL-CARCINOMA
    HALE, RJ
    BUCKLEY, CH
    FOX, H
    WILLIAMS, J
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (07) : 594 - 596
  • [8] EXPRESSION OF RAS ONCOGENE PRODUCT AND EGF RECEPTOR IN CERVICAL SQUAMOUS-CELL CARCINOMAS AND ITS RELATIONSHIP TO LYMPH-NODE INVOLVEMENT
    HAYASHI, Y
    HACHISUGA, T
    IWASAKA, T
    FUKUDA, K
    OKUMA, Y
    YOKOYAMA, M
    SUGIMORI, H
    [J]. GYNECOLOGIC ONCOLOGY, 1991, 40 (02) : 147 - 151
  • [9] C-ERBB-3 PROTOONCOGENE EXPRESSION IN UTERINE CERVICAL-CARCINOMA
    HUNT, CR
    HALE, RJ
    ARMSTRONG, C
    RAJKUMAR, T
    GULLICK, WJ
    BUCKLEY, CH
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (04) : 282 - 285
  • [10] KOHLER M, 1989, ANTICANCER RES, V9, P1537